Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sigurd M. Hald"'
Autor:
Erna-Elise Paulsen, Thomas Kilvaer, Mehrdad Rakaee Khanehkenari, Ramona Johansen Maurseth, Samer Al-Saad, Sigurd M. Hald, Khalid Al-Shibli, Sigve Andersen, Elin Richardsen, Lill-Tove Busund, Roy Bremnes, Tom Donnem
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 17, Iss 11, Pp 839-848 (2015)
Tumor-infiltrating lymphocytes (TILs) are vital in limiting cancer progression and may supplement the TNM classification. CD45RO+ memory TILs show major prognostic impact in various malignancies but have not been extensively explored in non–small c
Externí odkaz:
https://doaj.org/article/a838926a79934471a1af49ed71ea4c6d
Autor:
Lill-Tove Busund, Roy M. Bremnes, Francesco Pezzella, Sigve Andersen, Torkjel M. Sandanger, Yury Kiselev, Khalid Al-Shibli, Olfred Hansen, Henrik J. Ditzel, Karen Ege Olsen, Mette Poehl, Marius Lund-Iversen, Aslaug Helland, Odd Terje Brustugun, Thomas K. Kilvaer, Samer Al-Saad, Elin Richardsen, Erna-Elise Paulsen, Sigurd M. Hald, Tom Donnem
Purpose: Immunoscore is a prognostic tool defined to quantify in situ immune cell infiltrates, which appears to be superior to the tumor–node–metastasis (TNM) classification in colorectal cancer. In non–small cell lung cancer (NSCLC), no immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e1dcc8aa6c7cc89aa28450d8e80b7a9
https://doi.org/10.1158/1078-0432.c.6524199.v1
https://doi.org/10.1158/1078-0432.c.6524199.v1
Autor:
Lill-Tove Busund, Roy M. Bremnes, Francesco Pezzella, Sigve Andersen, Torkjel M. Sandanger, Yury Kiselev, Khalid Al-Shibli, Olfred Hansen, Henrik J. Ditzel, Karen Ege Olsen, Mette Poehl, Marius Lund-Iversen, Aslaug Helland, Odd Terje Brustugun, Thomas K. Kilvaer, Samer Al-Saad, Elin Richardsen, Erna-Elise Paulsen, Sigurd M. Hald, Tom Donnem
Supplemental Table II. Prognostic clinicopathologic variables as predictors for DFS in 797 NSCLS (univariate analysis,log-rank test)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f1c074a0a9179853cc8bb2ef1397caa
https://doi.org/10.1158/1078-0432.22459335
https://doi.org/10.1158/1078-0432.22459335
Autor:
Lill-Tove Busund, Roy M. Bremnes, Francesco Pezzella, Sigve Andersen, Torkjel M. Sandanger, Yury Kiselev, Khalid Al-Shibli, Olfred Hansen, Henrik J. Ditzel, Karen Ege Olsen, Mette Poehl, Marius Lund-Iversen, Aslaug Helland, Odd Terje Brustugun, Thomas K. Kilvaer, Samer Al-Saad, Elin Richardsen, Erna-Elise Paulsen, Sigurd M. Hald, Tom Donnem
Supplemental Figure 1. Disease-specific survival curves according to low, intermediate and high stromal CD8+ T-cell density in the Danish cohort (Odense University Hospital, n = 178). (A) Score from the invasive margin tumor area, (B) score from the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d373c08aa378af6575ee6a9f4151253
https://doi.org/10.1158/1078-0432.22459341.v1
https://doi.org/10.1158/1078-0432.22459341.v1
Autor:
Mehrdad Rakaee Khanehkenari, Erna-Elise Paulsen, Ramona Johansen Maurseth, Khalid Al-Shibli, Tom Donnem, Sigve Andersen, Roy M. Bremnes, Elin Richardsen, Lill-Tove Busund, Samer Al-Saad, Thomas Karsten Kilvær, Sigurd M. Hald
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 17, Iss 11, Pp 839-848 (2015)
Published version also available at http://dx.doi.org/10.1016/j.neo.2015.11.004 Tumor-infiltrating lymphocytes (TILs) are vital in limiting cancer progression and may supplement the TNM classification. CD45RO+ memory TILs show major prognostic impact
Autor:
Thomas Karsten Kilvær, Stig Manfred Dalen, Mehrdad Rakaee, Sigurd M. Hald, Erna-Elise Paulsen, Sigve Andersen, Roy M. Bremnes, Lill-Tove Busund, Samer Al-Saad, Tom Donnem, Elin Richardsen
Publikováno v:
Human pathology. 79
The presence of tumor-infiltrating lymphocytes (TILs) positively impacts the outcome of non-small cell lung cancer (NSCLC) patients. Most previous studies have assessed TILs using different immunohistochemical assays. The purpose of this study was to
Autor:
Yury Kiselev, Odd Terje Brustugun, Erna-Elise Paulsen, Thomas Karsten Kilvær, Lill-Tove Busund, Francesco Pezzella, Sigve Andersen, Roy M. Bremnes, Khalid Al-Shibli, Torkjel M. Sandanger, Elin Richardsen, Olfred Hansen, Sigurd M. Hald, Samer Al-Saad, Marius Lund-Iversen, Henrik J. Ditzel, Åslaug Helland, Karen Ege Olsen, Mette Poehl, Tom Donnem
Publikováno v:
Donnem, T, Hald, S M, Paulsen, E-E, Richardsen, E, Al-Saad, S, Kilvaer, T K, Brustugun, O T, Helland, A, Lund-Iversen, M, Poehl, M, Olsen, K E, Ditzel, H J, Hansen, O, Al-Shibli, K, Kiselev, Y, Sandanger, T M, Andersen, S, Pezzella, F, Bremnes, R M & Busund, L-T 2015, ' Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer ', Clinical Cancer Research, vol. 21, no. 11, pp. 2635-2643 . https://doi.org/10.1158/1078-0432.CCR-14-1905
Purpose: Immunoscore is a prognostic tool defined to quantify in situ immune cell infiltrates, which appears to be superior to the tumor–node–metastasis (TNM) classification in colorectal cancer. In non–small cell lung cancer (NSCLC), no immuno
Autor:
Tom Donnem, Sigve Andersen, Inigo Martinez, Sigurd M. Hald, Thomas Karsten Kilvær, Samer Al-Saad, Erna-Elise Paulsen, Lill-Tove Busund, Egil S. Blix, Elin Richardsen, Mehrdad Rakaee, Roy M. Bremnes
Publikováno v:
Clinical lung cancer. 19(3)
Background Lymphocyte activation gene-3 (LAG-3) is an immune checkpoint receptor and a putative therapeutic target in non–small-cell lung cancer (NSCLC). We explored the prognostic effect of LAG-3+ tumor-infiltrating lymphocytes (TILs) in primary t
Autor:
Sigve Andersen, Sigurd M. Hald, Roy M. Bremnes, Erna-Elise Paulsen, Mehrdad Rakaee, Elin Richardsen, Thomas Karsten Kilvær, Tom Donnem, Lill-Tove Busund
Publikováno v:
Cancer Immunology, Immunotherapy
The immune checkpoint receptor CTLA-4 plays a crucial part in negatively regulating T cell activation and maintaining self-tolerance. It is frequently overexpressed in a variety of malignancies, yet its prognostic impact in non-small cell lung cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55deb1e1e4738f8ea11d8e8886f06109
https://hdl.handle.net/10037/13322
https://hdl.handle.net/10037/13322
Autor:
Elin Richardsen, Khalid Al-Shibli, Roy M. Bremnes, Tom Donnem, Helge Stenvold, Samer Al-Saad, Sigurd M. Hald, Sigve Andersen, Marte Eilertsen, Lill-Tove Busund
Publikováno v:
Lung Cancer. 83:272-278
Objectives miR-210 is an important regulator of the cellular response to hypoxia. Therefore, we aimed to explore the prognostic significance of miR-210 in non-small cell lung cancer (NSCLC) patients with stage I-IIIA disease. Materials and methods In